Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NO 711

Copy Product Info
😃Good
Catalog No. T70414Cas No. 159094-94-7
Alias NO711, NNC-711 free acid

NO 711(NNC-711 free acid) is a potent and selective inhibitor of GABA transporter 1 (GAT-1), which increases GABAergic transmission, enhances non-rapid eye movement sleep, and prevents and treats paclitaxel-induced neuropathic pain.

NO 711

NO 711

Copy Product Info
😃Good
Purity: 99.70%
Catalog No. T70414Alias NO711, NNC-711 free acidCas No. 159094-94-7
NO 711(NNC-711 free acid) is a potent and selective inhibitor of GABA transporter 1 (GAT-1), which increases GABAergic transmission, enhances non-rapid eye movement sleep, and prevents and treats paclitaxel-induced neuropathic pain.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$293-In Stock
5 mg$722-In Stock
10 mg$987-In Stock
25 mg$1,520-In Stock
50 mg$1,980-In Stock
100 mg$2,500-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.70%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
NO 711(NNC-711 free acid) is a potent and selective inhibitor of GABA transporter 1 (GAT-1), which increases GABAergic transmission, enhances non-rapid eye movement sleep, and prevents and treats paclitaxel-induced neuropathic pain.
In vitro
Treatment of microglia with NO 711 (1 μM, 0-15 minutes) significantly reduced Na+-dependent GABA uptake. [2]
In vivo
Methods: 12-, 18-, and 25-day-old rat pups with implanted electrodes were used. Epileptic foci were induced by local application of dithiothreitol methyl iodide (BMI) via an implanted cannula over the sensorimotor cortical area, and cortical afterepileptic discharges (ADs) were induced by low-frequency stimulation (8 Hz) of the same cortical area. Epileptic foci were formed after pretreatment with NO 711 (1 or 10 mg/kg, i.p.), and epileptic ADs were induced in a second experimental series. NNC-711 was then applied at the same dose, and stimulation was repeated.
Results: NO 711 did not block the formation of epileptogenic foci, but it significantly inhibited the spontaneous transition of interictal focal to ictal activity in all age groups. In 18- and 25-day-old rats, the intensity of movements accompanying sensorimotor cortical stimulation was smaller under the influence of NNC-711. [1]
SynonymsNO711, NNC-711 free acid
Chemical Properties
Molecular Weight350.41
FormulaC21H22N2O3
Cas No.159094-94-7
SmilesOC(=O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy NO 711 | purchase NO 711 | NO 711 cost | order NO 711 | NO 711 chemical structure | NO 711 in vivo | NO 711 in vitro | NO 711 formula | NO 711 molecular weight